Related Experiment Video
Updated: Jun 12, 2026

An Open-Source Normothermic Perfusion System Designed for Research Scientists
Published on: July 18, 2025
Setbacks in blood substitutes research and development: a biochemical perspective
1Division of Hematology, Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration/PHS, 8800 Rockville Pike, Bethesda, MD 20892, USA. abdu.alayash@fda.hhs.gov
Recent challenges with hemoglobin-based oxygen carriers (HBOCs) necessitate novel approaches. This research identifies biochemical pathways contributing to adverse events, aiming to guide the development of safer HBOCs.
Area of Science:
- Biochemistry
- Biomedical Engineering
- Hematology
Background:
- Hemoglobin-based oxygen carriers (HBOCs) have faced setbacks due to adverse events.
- Understanding the biochemical mechanisms behind these adverse events is crucial for future development.
Purpose of the Study:
- To identify underlying biochemical pathways responsible for adverse events associated with HBOCs.
- To propose methods for controlling these pathways to enable the development of safer HBOCs.
Main Methods:
- Review of existing literature on HBOC adverse events.
- Focus on biochemical pathway analysis.
- Laboratory investigation of specific biochemical mechanisms.
Main Results:
- Identification of key biochemical pathways contributing to HBOC-related adverse events.
- Elucidation of mechanisms underlying toxicity.
- Proposed strategies for mitigating adverse effects.
Conclusions:
- Addressing identified biochemical pathways is essential for developing a safe and effective second generation of HBOCs.
- Further research into controlling these mechanisms will facilitate the clinical application of HBOCs.
More Related Videos
10:25Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
09:47Exploring Alternative Perfusion Solutions Using Next-Generation Polymerized Hemoglobin-Based Oxygen Carriers in a Model of Rat Ex Vivo Lung Perfusion
Published on: June 14, 2024
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...